GL1X · GenesisL1 explorer

MolNFT v1 · #173322 · protein

Mertk kinase domain with type 1.5 inhibitor from a DNA-encoded library

7AW2 · Tyrosine-protein kinase mer: “Mertk kinase domain with type 1.5 inhibitor from a DNA-encoded library”. X-ray diffraction, 1 ligand (S4W), 1 pocket (best druggability 0.66). MolNFT v1 #173322 on GenesisL1: 3D structure, binding sites…

PDB
7AW2
Type
protein
Length
270 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase mer
EC
2.7.10.1
UniProt
Q12866
Ligands
S4W
Pockets
1 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase mer (EC 2.7.10.1)protein27043% helix, 16% strandQ12866

Ligands and binding sites

  • S4W · 5-(2'-chloro-[1,1'-biphenyl]-4-yl)-N-(imidazo[1,2-a]pyridin-6-ylmethyl)-N-methyl-1,3,4-oxadiazol-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12990.660.8139S4W

Compared structures

  • 7AW2 · MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.